CPHI & PMEC China 2026
06/2026 – 06/2026
Über das Unternehmen
- Firmenname (rechtlich): Liaoning Pharmaceutical Innovation Co., Ltd.
- Registrierungsland: China
- Adresse: No.146 Northeast Great Road,, Dadong District, Shenyang
- Anzahl der Mitarbeiter: 25 - 49
Beschreibung:
Liaoning Pharmaceutical Innovation Co., Ltd. is located in the Fine Chemical Industry Development Park of Panjin City, Liaoning Province, covering an area of 2,000 square meters, with its synthesis area equipped with 21 multifunctional reactors and more than 30 auxiliary facilities capable of year-round production. The company operates a research and development center, a production workshop and a GMP production base, serving as a GMP manufacturer of veterinary APIs including Pimobendan, Trilostane, Afoxolaner, Oclacitinib Maleate, Barbital and Phenobarbital.
Geschäftsaktivitäten
Vertrags- & Outsourcing-Dienstleistungen
HerstellerVertriebspartner
ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch)
HerstellerVertriebspartner
Hauptprodukte/-dienstleistungen
- Tierarzneimittel & Futtermittelzusatzstoffe: Maropitant citrate, Pimobendan, Barbital, Trilostane, FLURALANER, Grapiprant, Oclacitinib Maleate, Afoxolaner, Phenobarbital, Romifidine Hydrochloride, Miltefosine, Atipamezole Hydrochloride, Alfaxalone, Toceranib Phosphate, Menbutone, Sarolaner, Lotilaner, Gleptoferron, Fulvestrant
Unsere Produkte & Dienstleistungen
Sell · Veterinary Pharmaceuticals & Feed Additives
Sell · Veterinary Pharmaceuticals & Feed Additives
Proofs
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen